Background This systematic review aimed to evaluate the performance of machine learning (ML) models in predicting post-treatment survival and disease progression outcomes …
D Hodson, H Mistry, J Yates, S Guzzetti… - European Journal of …, 2024 - Elsevier
Background Preclinical models of cancer can be of translational benefit when assessing how different biomarkers are regulated in response to particular treatments. Detection of …
W Luo, Z Xiu, X Wang, R McGarry, J Allen - Cancers, 2023 - mdpi.com
Simple Summary The assessment of tumor response is important in evaluating cancer treatment and predicting clinical outcomes. The currently used response evaluation criteria …
M Wilbaux, D Demanse, Y Gu, A Jullion… - CPT …, 2022 - Wiley Online Library
Abstract Machine learning (ML) opens new perspectives in identifying predictive factors of efficacy among a large number of patients' characteristics in oncology studies. The objective …
M Cerou, HT Thai, L Deyme… - CPT …, 2024 - Wiley Online Library
A joint modeling framework was developed using data from 75 patients of early amcenestrant phase I–II AMEERA‐1‐2 dose escalation and expansion cohorts. A semi …
By using the population level data of heterogeneous populations, statistical and mathematical approaches, such as Lasso and mixed effects modeling, to identify variables …